LOUIS P. LACASSE

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Armata Pharmaceuticals, Inc.

Filing Date Source Excerpt
2002-03-27 Louis P. Lacasse (age 45) has served as a director of Targeted Genetics since May 1998. Mr. Lacasse has served as president of GeneChem Management, Inc. and as manager of GeneChem Technologies Venture Fund L.P. and GeneChem Theraputics Venture Fund, L.P., two venture capital funds, since May 1997.
2003-03-27 Louis P. Lacasse (age 46) has served as a director of Targeted Genetics since May 1998. The members of the audit committee are Jeremy L. Curnock Cook, Louis P. Lacasse (chairman) and Nelson L. Levy.
2004-03-24 Louis P. Lacasse (age 47) has served as a director since May 1998. He is chairman of the audit committee. The audit committee members are Louis P. Lacasse (chairman), Jeremy L. Curnock Cook and Nelson L. Levy.
2005-04-14 Louis P. Lacasse (age 48) has served as a director of Targeted Genetics since May 1998. ... The members of the Audit Committee are Louis P. Lacasse (chairman), Jeremy L. Curnock Cook and Nelson L. Levy. ... The Nominating Committee held one meeting in 2004. The members of this committee are Nelson L. Levy (chairman), Jeremy L. Curnock Cook and Louis P. Lacasse.
2006-03-29 Louis P. Lacasse (age 49) has served as a director since May 1998. He serves on the Audit Committee. The Board of Directors has determined that Mr. Lacasse is an independent director.

Data sourced from SEC filings. Last updated: 2026-02-03